Hematuria and risk for end-stage kidney disease

Keyphrases

• Hematuria 100%
• Microscopic Hematuria 100%
• End-stage Kidney Disease 100%
• Follow-up Examination 66%
• Chronic Kidney Disease 66%
• Thin Basement Membrane Disease 66%
• Alport Syndrome 66%
• Young Person 66%
• IgA Nephropathy (IgAN) 66%
• Therapeutic Intervention 33%
• Blood Pressure 33%
• Medical Attention 33%
• Diagnostic Marker 33%
• Novel Diagnostics 33%
• Genetic Environment 33%
• Future Risk 33%
• Environment Interaction 33%
• Treatment Plan 33%
• Kidney Disease Progression 33%
• Benign Familial Hematuria 33%
• Environmental Treatment 33%
• Misnomer 33%
• Disease Syndrome 33%
• Evaluation Plan 33%
• Pressure Function 33%
• Loss-to-follow-up 33%
• Primary Glomerulonephritis 33%
• Kidney Function Tests 33%
• Urinalysis 33%
• Follow-up Treatment 33%

Medicine and Dentistry

• Hematuria 100%
• End Stage Renal Disease 100%
• Chronic Kidney Disease 50%
• Thin Basement Membrane Disease 33%
• Immunoglobulin A Nephropathy 33%
• Alport Syndrome 33%
• Disease 16%
• Blood Pressure 16%
• Clinical Finding 16%
• Urinalysis 16%
• Environment-Genetics Interaction 16%
• Kidney Function Test 16%
• Evaluation and Follow up 16%
• Diagnostic Marker 16%
• Glomerulopathy 16%